Showing results (101-110 of 369) with videos related to
Sort By:
Pageof 37
Future Oncology (London, England)|July 23, 2015
Cardio-oncology: an ongoing evolutionBradley J Petek, Chris Greenman, Joerg Herrmann, et al.Future Oncology (London, England)|August 19, 2021
Solitary fibrous tumor: molecular hallmarks and treatment for a rare sarcomaAlannah Smrke, Khin Thway, Paul H Huang, et al.Expert Review of Anticancer Therapy|June 17, 2017
Eribulin in advanced liposarcoma and leiomyosarcomaElisabetta Setola, Jonathan Noujaim, Charlotte Benson, et al.Future Oncology (London, England)|April 21, 2021
Pharmacotherapy for liposarcoma: current and emerging synthetic treatmentsFlorence Chamberlain, Charlotte Benson, Khin Thway, et al.Expert Opinion on Investigational Drugs|November 25, 2022
What's the latest with investigational drugs for soft tissue sarcoma?Elena Cojocaru, Andrea Napolitano, Cyril Fisher, et al.Expert Review of Gastroenterology & Hepatology|March 29, 2025
Identifying and managing rare subtypes of gastrointestinal stromal tumorsLeonidas Mavroeidis, Foteini Kalofonou, Ruth Casey, et al.Oncotargets and Therapy|June 11, 2016
Targeting gastrointestinal stromal tumors: the role of regorafenibBrett Schroeder, Zula Li, Lee D Cranmer, et al.Frontiers in Oncology|January 23, 2023
Exploring the landscape of immunotherapy approaches in sarcomasPampina Pilavaki, Myrofora Panagi, Samia Arifi, et al.Chemotherapy|January 4, 2022
KIT Exon 9-Mutated Gastrointestinal Stromal Tumours: Biology and TreatmentAndrea Napolitano, Khin Thway, Myles J Smith, et al.Current Oncology (Toronto, Ont.)|November 24, 2022
Alternate Pembrolizumab Dosing Interval in Advanced NSCLC with PD-L1 TPS ≥ 50%: 3 Weekly Compared to 6 Weekly DosingLauren Jones, Rebekah Rittberg, Bonnie Leung, et al.Pageof 37